Venture Capital

With over $20M in funding, DAPPOS launches xBubble, an AI agent that automates AI, aiming to eliminate prompt engineering for everyday users.

A new study reveals U.S. nonprofits are under siege from government actions, facing burnout and financial ruin while demand for their services soars.

As its oesophageal cancer vaccine enters trials, Infinitopes hires a top CSO with a track record of bringing breakthrough therapies to market.

Icomera's new compact XS1 router brings 5G and LEO satellite tech to metros and regional trains, aiming to close connectivity gaps and speed up fleet upgrades.

Biotech firm AstronauTx appoints a new CMO and VP, signaling a pivotal move to clinical trials for its novel Alzheimer's therapy targeting sleep architecture.

With five WOW Awards, including Promoter of the Year, TribeVibe cements its dominance, rewriting the rules for events from college towns to major arenas.

The medtech firm reports a 19% revenue surge and a return to profitability, validating its new pure-play strategy focused on the surgical market.

An all-women team at Kalos Ventures has closed an oversubscribed fund to back tech startups in workforce, care, and education amid AI and aging trends.

New research shows parents and voters reject simple tech bans, instead calling for digital literacy and comprehensive support for youth mental health.

America's largest sugar producer is launching a fleet of autonomous tractors, a move that promises greater efficiency but also reshapes the future of farm labor.

The chef-favorite cookware brand enters the mainstream, betting on Tennessee-made cast iron to reinvent a kitchen classic for discerning home cooks.

Malta's leading telecom, GO plc, partners with Connectbase, automating wholesale access to its vital fiber and subsea networks in Malta and Cyprus.

The cybersecurity firm released a new protocol for AI agent identity, a real-time zero-day tracker, and secured a key partnership with Anthropic.

A renewed alliance aims to break key supply chain bottlenecks in gene therapy, offering developers faster access to critical, regulatory-ready materials.

With a new CEO, Impossible Metals aims to scale its AI robots for ocean mining. But can its 'green' tech win over fierce environmental opposition?

Actuate Therapeutics gets FDA nod for its oral cancer drug elraglusib, shifting strategy to improve patient outcomes and tackle hard-to-treat tumors.

Two iconic American brands team up for a grooming line celebrating adventure and veteran support, tapping into a booming market for lifestyle products.

Macnica ATD Europe's strategic acquisition of Indesmatech aims to deepen its engineering presence and capture the booming IoT and semiconductor markets.

Anaveon reveals promising ASCO data for its cancer drug ANV600, yet puts the asset on the market to fund a bold new focus on autoimmune diseases.

Formula 1 meets pet couture as VETRESKA partners with Ollie Bearman, signaling a new era of lifestyle brand sponsorships in high-speed motorsport.